2026 NPPES data Research Study Specialist NPI 1073638615 MD, PHD
Verify on CMS →

DAVID GOLDSTEIN, MD, PHD

Research Study Specialist in BETHESDA, Maryland. CMS National Plan and Provider Enumeration System profile including specialty classification, practice address, and Medicare prescribing data when reported.

Federal data — no proprietary rating. PlainDoctor publishes the actual CMS NPPES and Medicare records — NPI registration, specialty, practice location, and prescribing data — without a composite score or editorial opinion on top. Every field traces to a federal source.
Prescribing volume
34
Medicare Part D claims · Research Study Specialist avg: 601
Industry payments
$53.77
3 payments · CMS Open Payments (Sunshine Act)
What the federal data reveals: DAVID GOLDSTEIN, MD, PHD is a Research Study Specialist ([object Object]) practicing in BETHESDA, Maryland with a Medicare Part D prescribing footprint of 34 claims . Industry payments of $53.77 across 3 transactions are disclosed under CMS Open Payments (Sunshine Act).

What stands out: DAVID GOLDSTEIN, MD, PHD filed 34 Medicare Part D claims in 2023 across BETHESDA, Maryland. Every figure on this page comes straight from federal CMS records, with no proprietary rating applied.

DAVID GOLDSTEIN, MD, PHD at a glance

Quality data not reported

NPI registry status

Active

Issued 03/20/2007

NPI 1073638615

Primary specialty

Research Study Specialist

Rare

472 US NPIs in this specialty

Medicare Part D claims

34 94% vs specialty avg

2023 prescription claims

Specialty avg: 601

Specialty distribution in Maryland

How Research Study Specialist compares to other specialties among Maryland providers

Maryland providers

Research Study Specialist share within Maryland

1. Research Study Specialist42%2. Internal medicine21%3. Family medicine17%4. Surgical12%5. Pediatric8%
Research Study Specialist share within Maryland

Specialty board-certification context

Estimated specialty board-certified rate — Research Study Specialist (ABMS / AOA reference)

Quality data not reported
Est. board-certified rate
78%
Research Study Specialist ABMS/AOA estimate

Est. board-certified rate (Research Study Specialist) — ABMS / AOA estimate

0%100%78%
Est. board-certified rate (Research Study Specialist) — ABMS / AOA estimate

The Merit-based Incentive Payment System (MIPS) scores providers 0–100 across four performance categories: Quality, Cost, Promoting Interoperability, and Improvement Activities, weighted under 42 CFR §414.1380. Reporting is voluntary for many small practices, so absence of a MIPS score is not a quality signal.

Board certification through an ABMS or AOA member board signals voluntary post-licensure examination plus continuous Maintenance of Certification cycles. Verify any individual provider's status through certificationmatters.org (ABMS) or osteopathic.org (AOA).

DAVID GOLDSTEIN, MD, PHD is a Research Study Specialist provider practicing in BETHESDA, Maryland, according to the CMS National Plan and Provider Enumeration System (NPPES). Credentials: MD, PHD. NPI: 1073638615. This profile includes practice location, specialty classification, and organizational affiliations from the CMS provider registry. Provider information is self-reported to CMS and updated monthly.

DAVID GOLDSTEIN, MD, PHD appears in the CMS NPPES registry as a Research Study Specialist provider holding MD, PHD credentials at 10 CENTER DR # MSC-1620, BETHESDA, MD, 20892, with a listed phone of (301) 496-2103. NPI 1073638615 was issued on 03/20/2007. Because NPPES data is self-reported by the provider and refreshed monthly, the address, phone, and specialty reflect what GOLDSTEIN most recently submitted to CMS rather than a vetted directory listing, which is why patients should always confirm the practice is still at this location before scheduling.

Medicare Part D records for calendar year 2023 show 34 prescription claims written by this provider, covering N/A Medicare beneficiaries and totaling roughly $6K in drug spend. These figures capture only Medicare Part D — commercial insurance, Medicaid, and cash-pay prescriptions are not included, and any drug-beneficiary cell under 11 is suppressed by CMS for patient privacy.

Research Study Specialist is a narrow specialty nationwide, with 472 enrolled providers across 41 states and an average of 601 Part D claims per prescriber, so the context for interpreting these metrics differs meaningfully from a primary-care baseline. Important: PlainDoctor is a directory of publicly available government data, not medical advice, a malpractice database, or a quality rating. Inclusion here does not imply a recommendation, and absence of complaints or sanctions on this page does not mean none exist — always verify credentials through the NPPES NPI Registry, your state medical board, and the ABMS or AOA before making healthcare decisions.

Practice Address

10 CENTER DR # MSC-1620
BETHESDA, MD 20892

Provider Details

NPI 1073638615
Specialty Research Study Specialist
Credentials MD, PHD
Gender Male
NPI Issued 03/20/2007

Industry payments received (2024) — CMS Open Payments transparency data

The federal Physician Payments Sunshine Act (part of the Affordable Care Act) requires drug and medical-device manufacturers + group purchasing organizations to publicly report payments and other transfers of value to physicians and teaching hospitals. The data below covers 2024 for DAVID GOLDSTEIN, MD, PHD. Source: openpaymentsdata.cms.gov.

Total received

$54

Largest payer

Novo Nordisk Inc

Most common payment type

Food and Beverage

Industry payments are not necessarily indicators of bias — they include research funding, consulting fees for evidence-based work, royalties for inventions, food at conferences, and similar items. The disclosure exists for transparency. Read our methodology for how we interpret this data.

Medicare Part D Prescribing Data

CMS Medicare Part D prescriber-level data for calendar year 2023.

34
Total Claims
$6K
Total Drug Cost
N/A
Medicare Beneficiaries

Prescribing Breakdown

30-Day Fills
52
Total Day Supply
1,464
Generic Drug Cost
$1K

Patient Demographics

Average Patient Age
78.6 years
Avg HCC Risk Score
1.32

Top Prescribed Drugs (Medicare Part D)

Top drugs by claim count for calendar year 2023. Based on Medicare Part D data only.

Drug Claims
Tamsulosin Hcl
11

* Counts below 11 are suppressed by CMS for patient privacy. Generic names shown where available from CMS Part D data.

Research Study Specialist Overview

How DAVID GOLDSTEIN, MD, PHD fits within the Research Study Specialist landscape nationally.

472
Research Study Specialist Providers in US
41
States with Research Study Specialist
601
Avg Claims per Provider

DAVID GOLDSTEIN, MD, PHD's 34 claims are below the specialty average of 601.

Nearby Research Study Specialist Providers in Maryland

Other clinicians with the same primary specialty enrolled in Maryland, drawn from the same CMS NPPES roster as GOLDSTEIN.

Compare Research Study Specialist nationally: see state-by-state distribution →

Frequently Asked Questions

What is DAVID GOLDSTEIN, MD, PHD's specialty?
DAVID GOLDSTEIN, MD, PHD specializes in Research Study Specialist and practices in BETHESDA, Maryland. Credentials: MD, PHD.
How much does DAVID GOLDSTEIN, MD, PHD prescribe under Medicare Part D?
In 2023, DAVID GOLDSTEIN, MD, PHD wrote 34 Medicare Part D claims totaling $6K in drug costs for N/A beneficiaries.
Where is DAVID GOLDSTEIN, MD, PHD located?
DAVID GOLDSTEIN, MD, PHD is located at 10 CENTER DR # MSC-1620, BETHESDA, MD, 20892. Phone: (301) 496-2103.
What is DAVID GOLDSTEIN, MD, PHD's NPI number?
DAVID GOLDSTEIN, MD, PHD's National Provider Identifier (NPI) is 1073638615, issued on 03/20/2007.
How many Research Study Specialist providers are there in the US?
There are 472 Research Study Specialist providers across 41 states in the US. The average Research Study Specialist provider writes 601 Medicare Part D claims per year.
What drugs does DAVID GOLDSTEIN, MD, PHD prescribe most often?
Based on 2023 Medicare Part D data, DAVID GOLDSTEIN, MD, PHD's most frequently prescribed drugs include Tamsulosin Hcl. This reflects Medicare Part D prescriptions only and does not include commercial insurance or other payer types.
Does DAVID GOLDSTEIN, MD, PHD accept Medicare?
DAVID GOLDSTEIN, MD, PHD appears in CMS Medicare data with 34 Part D claims and N/A Medicare beneficiaries in 2023. Contact the provider's office directly to confirm current Medicare enrollment and accepted plans.
How can I verify DAVID GOLDSTEIN, MD, PHD's credentials?
DAVID GOLDSTEIN, MD, PHD's NPI is 1073638615 with credentials MD, PHD. You can verify this through the NPPES NPI Registry, check state medical board records, and confirm board certification through the ABMS or AOA.

Data Sources

Provider Directory
CMS National Plan and Provider Enumeration System (NPPES), download.cms.gov/nppes, updated monthly. Contains NPI, specialty, credentials, and practice location.
Specialty Classification
NUCC Health Care Provider Taxonomy (nucc.org), the industry standard for classifying provider specialties in Medicare and Medicaid billing.
Prescribing Data
CMS Medicare Part D Prescriber Public Use File (2023). Includes claims, drug costs, beneficiaries, and opioid prescribing rates.
Limitations
Provider data is self-reported to CMS. Prescribing data reflects Medicare Part D only and does not include commercial insurance, Medicaid, or cash prescriptions. Claims below 11 beneficiaries are suppressed by CMS for privacy.

See our complete data methodology for details on how we collect and process government data.

Data as of April 2026 (NPPES) / 2023 (Medicare Part D). Source: Centers for Medicare & Medicaid Services (CMS).

Disclaimer: Data from CMS NPPES and Medicare Part D. PlainDoctor does not rate or rank providers. Provider information is self-reported and may not be current. Always verify information directly with the provider. About · Methodology